417 related articles for article (PubMed ID: 21419787)
21. Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test.
Dias Elpo Zomkowski A; Oscar Rosa A; Lin J; Santos AR; Calixto JB; Lúcia Severo Rodrigues A
Brain Res; 2004 Oct; 1023(2):253-63. PubMed ID: 15374751
[TBL] [Abstract][Full Text] [Related]
22. Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trial.
Gougoulaki M; Lewis G; Nutt DJ; Peters TJ; Wiles NJ; Lewis G
J Psychopharmacol; 2021 Aug; 35(8):919-927. PubMed ID: 33637001
[TBL] [Abstract][Full Text] [Related]
23. Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
Crawford AA; Lewis S; Nutt D; Peters TJ; Cowen P; O'Donovan MC; Wiles N; Lewis G
Psychopharmacology (Berl); 2014 Aug; 231(15):2921-31. PubMed ID: 24525810
[TBL] [Abstract][Full Text] [Related]
24. Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test.
Andreasen JT; Nielsen EØ; Christensen JK; Olsen GM; Peters D; Mirza NR; Redrobe JP
J Psychopharmacol; 2011 Oct; 25(10):1347-56. PubMed ID: 20360159
[TBL] [Abstract][Full Text] [Related]
25. Serotonin1B heteroreceptor activation induces an antidepressant-like effect in mice with an alteration of the serotonergic system.
Chenu F; David DJ; Leroux-Nicollet I; Le Maître E; Gardier AM; Bourin M
J Psychiatry Neurosci; 2008 Nov; 33(6):541-50. PubMed ID: 18982177
[TBL] [Abstract][Full Text] [Related]
26. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test.
Cryan JF; Valentino RJ; Lucki I
Neurosci Biobehav Rev; 2005; 29(4-5):547-69. PubMed ID: 15893822
[TBL] [Abstract][Full Text] [Related]
27. Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.
Lucas G; Du J; Romeas T; Mnie-Filali O; Haddjeri N; Piñeyro G; Debonnel G
PLoS One; 2010 Feb; 5(2):e9253. PubMed ID: 20169084
[TBL] [Abstract][Full Text] [Related]
28. Loss of Adult 5-HT1A Autoreceptors Results in a Paradoxical Anxiogenic Response to Antidepressant Treatment.
Turcotte-Cardin V; Vahid-Ansari F; Luckhart C; Daigle M; Geddes SD; Tanaka KF; Hen R; James J; Merali Z; Béïque JC; Albert PR
J Neurosci; 2019 Feb; 39(8):1334-1346. PubMed ID: 30552180
[TBL] [Abstract][Full Text] [Related]
29. The selective 5-HT 1A receptor agonist, NLX-112, overcomes tetrabenazine-induced catalepsy and depression-like behavior in the rat.
Jastrzębska-Więsek M; Wesołowska A; Kołaczkowski M; Varney MA; Newman-Tancredi A; Depoortere R
Behav Pharmacol; 2022 Aug; 33(5):333-341. PubMed ID: 35695543
[TBL] [Abstract][Full Text] [Related]
30. The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.
Sarkisyan G; Roberts AJ; Hedlund PB
Behav Brain Res; 2010 May; 209(1):99-108. PubMed ID: 20097233
[TBL] [Abstract][Full Text] [Related]
31. 5-HT 1A/1B receptor-mediated effects of the selective serotonin reuptake inhibitor, citalopram, on sleep: studies in 5-HT 1A and 5-HT 1B knockout mice.
Monaca C; Boutrel B; Hen R; Hamon M; Adrien J
Neuropsychopharmacology; 2003 May; 28(5):850-6. PubMed ID: 12637954
[TBL] [Abstract][Full Text] [Related]
32. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
[TBL] [Abstract][Full Text] [Related]
33. DPCPX, a selective adenosine A1 receptor antagonist, enhances the antidepressant-like effects of imipramine, escitalopram, and reboxetine in mice behavioral tests.
Szopa A; Poleszak E; Bogatko K; Wyska E; Wośko S; Doboszewska U; Świąder K; Wlaź A; Dudka J; Wróbel A; Wlaź P; Serefko A
Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1361-1371. PubMed ID: 30094458
[TBL] [Abstract][Full Text] [Related]
34. Characterization of 5-HT(1A/1B)-/- mice: an animal model sensitive to anxiolytic treatments.
Guilloux JP; David DJ; Xia L; Nguyen HT; Rainer Q; Guiard BP; Repérant C; Deltheil T; Toth M; Hen R; Gardier AM
Neuropharmacology; 2011 Sep; 61(3):478-88. PubMed ID: 21333660
[TBL] [Abstract][Full Text] [Related]
35. Evidence for the involvement of the serotonergic 5-HT(1A) receptors in the antidepressant-like effect caused by hesperidin in mice.
Souza LC; de Gomes MG; Goes AT; Del Fabbro L; Filho CB; Boeira SP; Jesse CR
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():103-9. PubMed ID: 22996046
[TBL] [Abstract][Full Text] [Related]
36. Altered expression of 5-HT1A receptors in adult rats induced by neonatal treatment with clomipramine.
Limón-Morales O; Soria-Fregozo C; Arteaga-Silva M; Vázquez-Palacios G; Bonilla-Jaime H
Physiol Behav; 2014 Jan; 124():37-44. PubMed ID: 24211235
[TBL] [Abstract][Full Text] [Related]
37. The role of 5-HT1A receptors in mediating acute negative effects of antidepressants: implications in pediatric depression.
Rahn KA; Cao YJ; Hendrix CW; Kaplin AI
Transl Psychiatry; 2015 May; 5(5):e563. PubMed ID: 25942044
[TBL] [Abstract][Full Text] [Related]
38. Antidepressant-like effects of sodium butyrate in combination with estrogen in rat forced swimming test: involvement of 5-HT(1A) receptors.
Zhu H; Huang Q; Xu H; Niu L; Zhou JN
Behav Brain Res; 2009 Jan; 196(2):200-6. PubMed ID: 18817816
[TBL] [Abstract][Full Text] [Related]
39. Serotonergic receptor mechanisms underlying antidepressant-like action in the progesterone withdrawal model of hormonally induced depression in rats.
Li Y; Raaby KF; Sánchez C; Gulinello M
Behav Brain Res; 2013 Nov; 256():520-8. PubMed ID: 24016840
[TBL] [Abstract][Full Text] [Related]
40. No effects of antidepressants on negative symptoms in schizophrenia.
Hinkelmann K; Yassouridis A; Kellner M; Jahn H; Wiedemann K; Raedler TJ
J Clin Psychopharmacol; 2013 Oct; 33(5):686-90. PubMed ID: 23857309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
